Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer
Maud de Dieuleveult, Claire Marchal, Anne Jouinot, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1106-1106
Open Access | Times Cited: 13

Showing 13 citing articles:

Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
Qihai Sui, Zhencong Chen, Zhengyang Hu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 31
Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics.
Khaled S. Allemailem, Ahmad Almatroudi, Faris Alrumaihi, et al.
PubMed (2021) Vol. 13, Iss. 4, pp. 3868-3889
Closed Access | Times Cited: 39
An overview of publicly available patient-centered prostate cancer datasets
Tim Hulsen
Translational Andrology and Urology (2019) Vol. 8, Iss. S1, pp. S64-S77
Open Access | Times Cited: 21
ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression
Guanxiong Ding, Wei Lu, Qing Zhang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 13
Heterozygous loss of Zbtb38 leads to early embryonic lethality via the suppression of Nanog and Sox2 expression
Miki Nishio, Takuya Matsuura, Shunya Hibi, et al.
Cell Proliferation (2022) Vol. 55, Iss. 4
Open Access | Times Cited: 8
Context-dependent CpG methylation directs cell-specific binding of transcription factor ZBTB38
Claire Marchal, Pierre‐Antoine Defossez, Benoît Miotto
Epigenetics (2022) Vol. 17, Iss. 13, pp. 2122-2143
Open Access | Times Cited: 7
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
Takuro Hirano, Eri Arai, Mao Fujimoto, et al.
Journal of Gynecologic Oncology (2022) Vol. 33, Iss. 6
Open Access | Times Cited: 6
Identification of multi-cancer risk genes
S. Rivera
(2024)
Open Access
Zbtb38 inhibits apoptosis by transcriptionally regulating XIAP expression
Eishou Matsuda, Toshiaki Shigeoka, H. Nagaoka, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Uncovering immune cell-associated genes in breast cancer: based on summary data-based Mendelian randomized analysis and colocalization study
Jingyang Liu, Wen Sun, Ning Li, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access
Role of ZBTB38 Genotype and Expression in Growth and Response to Recombinant Human Growth Hormone Treatment
Samuel J. H. Parsons, Adam Stevens, Andrew Whatmore, et al.
Journal of the Endocrine Society (2022) Vol. 6, Iss. 3
Open Access | Times Cited: 3
Low replication stress leads to specific replication timing advances associated to chromatin remodelling in cancer cells
Lilas Courtot, Elodie Bournique, Chrystelle Maric, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Heterozygous loss of ZBTB38 leads to early embryonic lethality in mice via suppressing Nanog and Sox2
Miki Nishio, Takuya Matsuura, Shunya Hibi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top